JBIC Journal of Biological Inorganic Chemistry
14. Abbadi BL, Rodrigues-Junior VS, Dadda AS, Pissinate K, Villela
AD, Campos MM, Lopes LGF, Bizarro CV, Machado P, Sousa
EHS, Basso LA (2018) Is IQG-607 a potential metallodrug or
metallopro-drug with a defned molecular target in Mycobacte-
rium tuberculosis? Front Microbiol 9:880
Additionally, we are also in debt with Iury A. Paz, Renata Oliveira
Santiago and Ariana Gomes da Silva for their assistance on the pre-
liminary biological studies.
Compliance with ethical standards
15. Zhang Y, Mitchison D (2003) The curious characteristics of
pyrazinamide: a review. Int J Tuberc Lung Dis 7:6–21
Conflict of interest The authors declare have no confict of interest.
16. Vandal OH, Nathan CF, Ehrt S (2009) Acid resistance in Myco-
bacterium tuberculosis. J Bacteriol 191:4714–4721
Ethical approval All procedures were performed according to the ethics
17. Zhang Y, Mitchison D, Shi W, Zhang W (2014) Mechanisms
of pyrazinamide action and resistance. Microbiol. Spectr. 2:
MGM2-0023-2013
committee of State University of Ceará number 2897836/15.
18. Njire M, Tan Y, Mugweru J, Wang C, Guo J, Yew W, Tan S,
Zhang T (2016) Pyrazinamide resistance in Mycobacterium tuber-
culosis: review and update. Adv Med Sci 61:63–71
References
19. Stehr M, Elamin AA, Singh M (2015) Pyrazinamide: the impor-
tance of uncovering the mechanisms of action in mycobacteria.
Expert Rev Anti Infect Ther 13:593–603
74:1041–1045
20. Pires BM, Jannuzzi SAV, Formiga ALB, Bonacin JA (2014) Prus-
sian blue flms produced by pentacyanidoferrate(II) and their
application as active electrochemical layers. Eur J Inorg Chem
2014:5812–5819
3. Rustomjee R, Zumla A (2015) Delamanid expanded access
novel treatment of drug resistant tuberculosis. Infect Drug Resist
8:359–366
21. Becke AD (1993) Density-functional thermochemistry. III. The
role of exact exchange. J Chem Phys 98:5648–5652
22. Lee C, Yang W, Parr RG (1988) Development of the Colle-Salvetti
correlation-energy formula into a functional of the electron den-
sity. Phys Rev B 37:785–789
4. Matsumoto M, Hashizume H, Tomishige T, Kawasaki M, Tsub-
ouchi H, Sasaki H, Shimokawa Y, Komatsu M (2006) OPC-67683,
a nitro-dihydro-imidazooxazole derivative with promising action
against tuberculosis in vitro and in mice. PloS Med 3:e466
5. Singh R, Manjunatha U, Boshof HIM, Ha YH et al (2008) PA-824
Kills Nonreplicating Mycobacterium tuberculosis by Intracellular
NO Release. Science 322:1392–1395
23. Stephens PJ, Devlin FJ, Chabalowski CF, Frisch MJ (1994) Ab Ini-
tion calculation of vibrational absorption and circular dichro-
ism spectra using density functional force felds. J Phys Chem
98:11623–11627
24. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA,
Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson
GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF,
Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K,
Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao
O, Nakai H, Vreven T, Montgomery JA Jr, Peralta JE, Ogliaro
F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN,
Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC,
Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M,
Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts
R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C,
Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth
GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas
O, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2013) Gaussian
09, Revision D.01. Gaussian Inc, Wallingford
6. Laborde J, Deraeve C, Bernardes-Génisson V (2017) Update of
antitubercular prodrugs from a molecular perspective: mecha-
nism of action, bioactivation pathways and associated resistance.
ChemMedChem 12:1657–1676
7. Lopez BE, Shinnyashiki M, Han TH, Fukuto JM (2007) Anti-
oxidant actions of nitroxyl (HNO). Free Radical Biol Med
42:482–491
8. Norris AJ, Sartippour MR, Lu M, Park T, Rao JY, Jackson MI,
Fukuto JM, Brooks MN (2008) Nitroxyl inhibits breast tumor
growth and angiogenesis. Int J Cancer 122:1905–1910
9. Nelli S, McIntosh L, Martin W (2001) Role of copper ions and
cytochrome P450 in the vasodilator actions of the nytroxyl
anion generator, Angeli’s salt, on rat aorta. Eur J Pharmacol
412:281–289
10. Sousa EHS, Basso LA, Santos DS, Diógenes ICN, Longhinotti E,
Lopes LGF, Moreira IS (2012) Isoniazid metal complex reactivity
and insights for a novel anti-tuberculosis drug design. J Biol Inorg
Chem 17:275–283
25. Tomasi J, Mennucci B, Cammi R (2005) Quantum mechanical
continuum solvation models. Chem Rev 105:2999–3093
26. O’Boyle NM, Tenderholt AL, Langner KM (2008) Cclib: a library
for package-independent computational chemistry algorithms. J
Comput Chem 29:839–845
11. Basso LA, Schneider CZ, Santos AJAB, Santos AA Jr, Campos
MM, Souto AA, Santos DS (2010) An inorganic complex that
inhibits mycobacterium tuberculosis enoyl reductase as a proto-
type of a new class of chemotherapeutic agents to treat tubercu-
losis. J Braz Chem Soc 21:1384–1389
27. Giacobbo BC, Pissinate K, Rodrigues-Junior V, Villela AD,
Grams ES, Abbadi BL, Subtil FT, Sperotto N, Trindade RV, Back
DF, Campos MM, Basso LA, Machado P, Santos DS (2017) New
insights into the SAR and drug combination synergy of 2-(quino-
lin-4-yloxy)acetamides against Mycobacterium tuberculosis. Eur
J Med Chem 126:491–501
12. Sousa EHS, Pontes DL, Diogènes ICN, Lopes LGF, Oliveira JS,
Basso LA, Santos DS, Moreira IS (2005) Electron transfer kinet-
ics and mechanistic study of the thionicotinamide coordinated to
the pentacyanoferrate(III)/(II) complexes: a model system for the
in vitro activation of thioamides anti-tuberculosis drugs. J Inorg
Biochem 99:368–375
28. Kushner S, Dalalian H, Sanjurjo JL, Bach FL Jr, Safr SR, Smith
VK Jr, Williams JH (1952) Experimental chemotherapy of tuber-
culosis. II. The Synthesis of pyrazinamides and related com-
pounds. J Am Chem Soc 74:3617–3621
13. Abbadi BL, Villela AD, Rodrigues-Junior VS, Subtil FT, Dalberto
PF, Pinheiro APS, Santos DS, Machado P, Basso LA, Bizarro CV
(2018) Revisiting activation of and mechanism of resistance to
compound IQG-607 in Mycobacterium tuberculosis. Antimicrob
Agents Chemother 62:e2222–e2317
29. Zhang YY, Gao W-X, Lin Y-J, Mi L-W, Jin G-X (2017) Syntheses,
structures, and solution studies of multicomponent macrocycles
and cages based on versatile ligands. Chem Eur J 23:11133–11140
30. Hackley BE Jr, Plafnger R, Stolberg M, Wagner-Jauregg T (1955)
Accelaration of the hydrolysis of organic fuoro-phosphates and
1 3